Zambia is accusing the United States of tying a $2 billion deal for critical health assistance to access to the southern African nation’s rich mineral assets, a direct challenge to national self-determination. Zambia’s foreign affairs minister, Mulambo Haimbe, on Monday, called the outgoing U.S. ambassador’s allegations of corruption “mischievous” and “undiplomatic,” bringing into the open simmering tensions over the Trump administration’s transactional approach to foreign aid.
Haimbe specifically accused the U.S. of tying access to critical minerals to the conclusion of the health deal. He also cited “unacceptable” data-sharing demands “in violation of our citizens’ right to privacy” and “the insistence on preferential treatment of U.S companies over Zambia’s critical minerals” as reasons for stalled negotiations. These demands represent a significant encroachment on Zambia's sovereign control over its resources and its people's data.
Zambia, through Minister Haimbe, has asserted that it “takes the view, first and foremost, that Zambians must have a say on how her critical minerals are used, and second that no one strategic partner is to be treated preferentially to others.” This stance highlights a national resistance to the systematic reduction of self-determination by external powers.
The New Colonialism of Aid
The comments by Minister Haimbe on Monday, May 4, 2026, brought into the open simmering tensions over President Donald Trump’s “America First” strategy. This strategy is reshaping aid to Africa into transactional agreements, a shift criticized by some African leaders and health experts who warn of demands for sensitive health data in exchange for badly needed support for health systems already strained by the Trump administration’s dismantling of foreign aid. Some critics fear they would not receive access to health innovations like vaccines in return, echoing past experiences where African nations contributed data but were last in line for treatments.
The U.S. is also actively seeking to challenge China, which is a dominant player in Zambia and much of Africa. The minerals in question, including inputs for solar panels, electric vehicle batteries, and energy storage systems, are critical to the global green energy transition, making control over them a strategic imperative for elite interests.
Outgoing U.S. ambassador Michael Gonzales had earlier dismissed Zambia's allegations of mineral-aid linkage as “alarmist allegations” that he called “disgusting” and “absolutely and patently false.” In late April 2026, Gonzales had also accused Zambian leaders of having “abdicated their responsibilities, letting the United States pay for healthcare while officials diverted government funds to their own pockets,” claiming Zambian authorities had “ignored” U.S. overtures to conclude a new deal.
Erosion of National Sovereignty
The U.S. approach replaces decades of engagement anchored in the now-dismantled United States Agency for International Development and the President’s Emergency Plan for AIDS Relief (PEPFAR). In their place, U.S. officials are negotiating country-by-country agreements that recast aid as a transaction, tying funding to conditions including commercial provisions, domestic financing commitments, disease surveillance, pathogen sharing, and even religion. Since late 2025, the U.S. has signed agreements with about 30 countries, many in Africa, systematically altering the terms of engagement.
Washington states this new approach is meant to reduce donor dependency, promote local ownership, and safeguard American interests, particularly against an aggressive China that dominates trade in Africa but contributes less aid. However, this framework is being met with significant pushback from sovereign nations.
Ghana last week rejected a proposed deal over provisions granting broad access to sensitive health data without safeguards. Zimbabwe walked away from a $367 million package in February 2026 over similar concerns. In Kenya, a $2.5 billion agreement signed in December 2025 has been put on hold after a court challenge arguing it violates data protection laws. In Lesotho, draft U.S. proposals sought 25 years of access to health data and biological samples before local officials secured a shorter five-year deal, demonstrating a pattern of elite pressure and national resistance.
Critics contend that the data-sharing demands disproportionately tilt toward U.S. interests, warning that information-sharing would largely flow in just one direction: toward Washington. This one-way flow of sensitive national data represents a significant transfer of informational sovereignty.
Elite Interests and Globalist Mechanisms
The new agreements aim to ensure the flow of disease surveillance data and biological samples, but through bilateral channels, following the U.S. withdrawal from the World Health Organization in January 2026. Countries currently report disease outbreaks primarily through the WHO, which coordinates responses and is negotiating new frameworks on pathogen-sharing and equitable access to vaccines. The U.S., now outside those talks, is pursuing direct access instead, effectively creating a parallel global health system that bypasses established international institutions.
Jen Kates, a senior vice president at the Washington-based non-profit KFF, noted, “They (the U.S.) want to understand what’s actually happening,” but added, “But they are trying to do it in a very different way.” Health advocates warn this risks creating a fragmented global health system, undermining collective action.
In Zimbabwe, a government spokesperson in February 2026 stated that negotiations were terminated because the U.S. was not offering a “corresponding guarantee of access to any medical innovations — such as vaccines, diagnostics, or treatments — that might result from that shared data.” Atilla Kisla of the Southern Africa Litigation Center commented, “That raises serious concerns about who benefits,” highlighting the elite interests at play.
The agreements with the U.S. are drawing criticism for closed-door negotiations and limited public scrutiny. Asia Russell, executive director of advocacy group Health GAP, stated, “Secrecy is at the center of this. That puts accountability for results at risk,” and added, “It’s impossible to evaluate these deals properly without seeing the full terms. Part of what made PEPFAR successful was transparency. Now that’s been taken away.” This lack of transparency serves to obscure the true costs to the native populations.
The deals also come with tighter financial conditions, often including reduced funding compared to previous levels of U.S. assistance, while requiring countries to increase domestic health spending, with aid at risk if targets are not met. KFF’s Kates observed, “These are going to be very heavy lifts,” as “Countries are already under strain.” Critics argue some agreements advance U.S. commercial and political interests, blurring the line between aid and transactional diplomacy, a form of elite capture. Russell warned, “When health becomes a bargaining chip, everyone becomes less safe,” underscoring the broader implications of these sovereignty-eroding policies. Keketso Phakela in Maseru, Lesotho, contributed to this report.